sapropterin has been researched along with Neurodegenerative Diseases in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ha, SH; Han, J; Kim, HK | 1 |
Choi, HJ; Hwang, O; Kim, SW; Lee, SY | 1 |
Kotsonis, P; Matter, H | 1 |
Choi, JJ; Choi, JW; Kim, HC; Kim, HS; Kim, WK; Ko, KH; Lee, JC; Lee, SJ; Ryu, JR; Shin, CY | 1 |
2 review(s) available for sapropterin and Neurodegenerative Diseases
Article | Year |
---|---|
Potential therapeutic applications of tetrahydrobiopterin: from inherited hyperphenylalaninemia to mitochondrial diseases.
Topics: Animals; Antioxidants; Binding Sites; Biopterins; Humans; Mice; Mice, Transgenic; Mitochondria; Mitochondrial Diseases; Models, Biological; Mutation; Neurodegenerative Diseases; Phenylketonurias; Reactive Oxygen Species | 2010 |
Biology and chemistry of the inhibition of nitric oxide synthases by pteridine-derivatives as therapeutic agents.
Topics: Animals; Arginine; Binding Sites; Biopterins; Brain Ischemia; Enzyme Inhibitors; Humans; Inflammation; Isoenzymes; Neurodegenerative Diseases; Nitric Oxide Synthase; Protein Conformation; Pteridines; Quantitative Structure-Activity Relationship; Sepsis; Structure-Activity Relationship | 2004 |
2 other study(ies) available for sapropterin and Neurodegenerative Diseases
Article | Year |
---|---|
Dopamine-dependent cytotoxicity of tetrahydrobiopterin: a possible mechanism for selective neurodegeneration in Parkinson's disease.
Topics: Animals; Antioxidants; Biopterins; Cell Death; Cell Line; Central Nervous System; Dopamine; Humans; Iron Chelating Agents; Lipid Peroxidation; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; NAD(P)H Dehydrogenase (Quinone); Neuroblastoma; Neurodegenerative Diseases; Oxidative Stress; Parkinson Disease; Proteins; Quinones; Toxicity Tests; Tyrosine 3-Monooxygenase | 2003 |
Glucose deprivation decreases nitric oxide production via NADPH depletion in immunostimulated rat primary astrocytes.
Topics: Adjuvants, Immunologic; Animals; Animals, Newborn; Astrocytes; Biopterins; Cell Death; Cells, Cultured; Central Nervous System; Deoxyglucose; Down-Regulation; Glucose; Glutathione; Interferon-gamma; Lactic Acid; Lipopolysaccharides; NADP; Neurodegenerative Diseases; Nitric Oxide; Nitric Oxide Synthase; Pyruvic Acid; Rats; Rats, Sprague-Dawley | 2002 |